COSTA MESA, Calif.--(BUSINESS WIRE)--Synthetic Blood International, Inc. (OTCBB:SYBD) lead product Oxycyte® is the subject of an article in today’s Miami Herald. The article appears in the paper’s health section under the headline: “Artificial blood goes from science fiction to science fact.” Oxycyte is the company’s perfluorocarbon (PFC) therapeutic oxygen carrier and blood substitute.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.